Comment from Disability Rights Education and Defense Fund

AnonymousSupportAdvocacy
Summary: The Disability Rights Education and Defense Fund (DREDF) supports the petition to prevent the FDA from reinstating in-person dispensing requirements for mifepristone. They argue that such requirements create illegal structural barriers for people with disabilities, who rely on telemedicine and mail delivery to overcome physical, transportation, and financial obstacles to healthcare.
See attached comments from the Disability Rights Education and Defense Fund (DREDF) in Support of Citizen Petition FDA-2025-P-2162-0001

View on Regulations.gov